| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Cletoquine oxalate；Desethylhydroxychloroquine oxalate |
氯托喹草酸 |
14142-64-4 |
詳細
|
| CK2/PIM1-IN-1 |
(E)-2-(5-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid |
292640-28-9 |
詳細
|
| CKI-7 free base；CKI-7 |
CKI-7 |
120615-25-0 |
詳細
|
| Cl-amidine |
N-[(1S)-1-(氨基羰基)-4 -[(2 - 氯-1-亞氨基乙基氨基]丁基]-苯甲酰胺 |
913723-61-2 |
詳細
|
| Cipemastat；Ro 32-3555 |
CIPEMASTAT |
190648-49-8 |
詳細
|
| Cinnarizine D8 |
八氘代桂利嗪 |
1185242-27-6 |
詳細
|
| Cicloprolol hydrochloride |
1-[4-[2-(環(huán)丙基甲氧基)乙氧基]苯氧基]-3-[(異丙基)氨基]-2-丙醇鹽酸鹽 |
63686-79-3 |
詳細
|
| CK2/ERK8-IN-1 |
CK2/ERK8-IN-1 |
1085822-09-8 |
詳細
|
| Theophylline |
茶堿 |
58-55-9 |
詳細
|
| CL 316243 |
CL 316243 |
138908-40-4 |
詳細
|
| Cl-amidine hydrochloride |
N-[(1S)-1-(氨基羰基)-4 -[(2 - 氯-1-亞氨基乙基氨基]丁基]-苯甲酰胺鹽酸鹽 |
1373232-26-8 |
詳細
|
| CLK1-IN-1 |
2123491-32-5 |
2123491-32-5 |
詳細
|
| Clocapramine dihydrochloride hydrate；3-Chlorocarpipramine hydrochloride hydrate;Clocapramine hydrochloride hydrate |
CLOCAPRAMINE HYDROCHLORIDE HYDRATE |
60789-62-0 |
詳細
|
| Cipropride S enantiomer |
Cipropride (S enantiomer) |
66183-70-8 |
詳細
|
| Cinnamoylglycine |
N-肉桂酰甘氨酸 |
16534-24-0 |
詳細
|
| Clocapramine；Clocarpramine;3-Chlorocarpipramine |
CLOCAPRAMINE |
47739-98-0 |
詳細
|
| Closthioamide |
Closthioamide |
1227367-59-0 |
詳細
|
| Cletoquine |
克尼托喹 |
4298-15-1 |
詳細
|
| CHMFL-ABL/KIT-155；CHMFL-ABL-KIT-155 |
CHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155; COMPOUND 34) |
2081093-21-0 |
詳細
|
| CHMFL-EGFR-202 |
CHMFL-EGFR-202 |
2089381-40-6 |
詳細
|
| CHMFL-KIT-033 |
CHMFL-KIT-033 |
2351801-41-5 |
詳細
|
| Cholesterol glucuronide |
|
17435-78-8 |
詳細
|
| Cholesteryl arachidonate |
CHOLESTERYL ARACHIDONATE |
604-34-2 |
詳細
|
| Cholesteryl Linolenate |
膽甾烯基亞麻酸酯 |
2545-22-4 |
詳細
|
| CHPG |
CHPG |
170846-74-9 |
詳細
|
| CHMFL-PI3KD-317 |
CHMFL-PI3KD-317 |
2244992-76-3 |
詳細
|
| CHPG sodium salt |
CHPG SODIUM SALT |
1303993-73-8 |
詳細
|
| Chromomycin A3 |
色霉素A3 |
7059-24-7 |
詳細
|
| Naftidrofuryl oxalate |
萘呋胺酯草酸鹽 |
3200-06-4 |
詳細
|
| Ciraparantag；PER977 |
(2S,2'S)-N,N'-(1,4-哌嗪二基二-3,1-丙烷二基)二[2-氨基-5-[(氨基亞胺甲基)氨基]戊酰胺] |
1438492-26-2 |
詳細
|
| Ciraparantag TFA；PER977 TFA |
|
1438492-27-3 |
詳細
|
| Cirsimarin |
濱薊黃甙 |
13020-19-4 |
詳細
|
| trans-Pralsetinib；cis-Pralsetinib;cis-BLU-667 |
cis-Pralsetinib hydrochloride (cis-BLU-667 hydrochloride) |
2097132-93-7 |
詳細
|
| Citrinin；NSC 186 |
桔霉素 |
518-75-2 |
詳細
|
| Cl-amidine TFA |
Cl-Amidine |
1043444-18-3 |
詳細
|
| CL2-SN-38 |
CL2-SN38 |
1036969-20-6 |
詳細
|
| CL264 |
CL264 |
1510712-69-2 |
詳細
|
| CL656；c-[2’FdAMP(S)-2’FdIMP(S)] |
CL656 |
1951464-79-1 |
詳細
|
| Chymase-IN-1 |
862090-74-2 |
862090-74-2 |
詳細
|
| Cilobradine hydrochloride |
西洛雷定鹽酸鹽 |
186097-54-1 |
詳細
|
| Cinacalcet metabolite M4 |
3-三氟甲基苯丙胺 |
104774-87-0 |
詳細
|
| Benzyl isothiocyanate |
十二(烷)酸芐酯苯基酯 |
622-78-6 |
詳細
|
| Cirsiliol |
條葉薊素 |
34334-69-5 |
詳細
|
| cis-Urocanic acid |
(E)-3-(3H-咪唑-4-基)丙-2-烯酸 |
7699-35-6 |
詳細
|
| CK-666 |
CK666 |
442633-00-3 |
詳細
|
| Clozic |
氯丁扎利 |
22494-47-9 |
詳細
|
| Theophylline monohydrate |
茶堿一水合物 |
5967-84-0 |
詳細
|
| Apramycin sulfate |
硫酸阿布拉霉素 |
65710-07-8 |
詳細
|
| Clomipramine D3 |
CLOMIPRAMINE-D3 |
136765-29-2 |
詳細
|
| CM-579 |
CM-579 |
1846570-40-8 |
詳細
|
| CM-675 |
CM-675 |
1872466-47-1 |
詳細
|
| CRA-026440 |
847460-34-8 |
847460-34-8 |
詳細
|
| CRAC intermediate 1 |
1249343-86-9 |
1249343-86-9 |
詳細
|
| Clomipramine D3 hydrochloride |
鹽酸氯米帕明-D3 |
1398065-86-5 |
詳細
|
| CMF019 |
Hexanoic acid, 3-[[[1-(1-ethylpropyl)-2-(2-thienylmethyl)-1H-benzimidazol-5-yl]carbonyl]amino]-5-methyl-, (3S)- |
1586787-08-7 |
詳細
|
| CMI-392 |
205654-37-1 |
205654-37-1 |
詳細
|
| CMK |
1-[4-氨基-7-(3-羥基丙基)-5-(4-甲基苯基)-7H-吡咯并[2,3-D]嘧啶-6-基]-2-氯乙酮 |
821794-90-5 |
詳細
|
| CMLD010509；SDS-1-021 |
CMLD010509 |
256497-58-2 |
詳細
|
| CO23 |
2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]- |
1370363-74-8 |
詳細
|
| CMP-5 |
1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine |
880813-42-3 |
詳細
|
| L-Glutathione reduced |
谷胱甘肽 |
70-18-8 |
詳細
|
| CMLD012072 |
CMLD012072 |
2368900-33-6 |
詳細
|
| Corin |
CORIN |
1808113-09-8 |
詳細
|
| Vitamin D2 |
維生素D2 |
50-14-6 |
詳細
|
| Glutathione oxidized |
L-谷胱甘肽 (氧化型) |
27025-41-8 |
詳細
|
| COH34 |
化合物 T10859 |
906439-72-3 |
詳細
|
| Collagen proline hydroxylase inhibitor |
N-乙基-7,10-二氫-8-硝基-7-氧代-N-乙基-1,10-菲羅啉-3-甲酰胺 |
223666-07-7 |
詳細
|
| Collagen proline hydroxylase inhibitor-1 |
膠原脯氨酸羥化酶抑制劑-1 |
223663-32-9 |
詳細
|
| COH34 analog 1 |
COH34 analog 1 |
314248-24-3 |
詳細
|
| CNT2 inhibitor-1 |
化合物CNT2 抑制劑-1 |
880155-70-4 |
詳細
|
| CNS-5161 hydrochloride |
160756-38-7 |
160756-38-7 |
詳細
|
| Coenzyme A |
輔酶 A |
85-61-0 |
詳細
|
| Col003 |
COL003 |
328565-16-8 |
詳細
|
| Complement C5-IN-1 |
COMPOUND C5-IN-1 (COMPOUND 7) |
2365402-67-9 |
詳細
|
| Cobimetinib (R-enantiomer)；XL-518 R-enantiomer;GDC-0973 R-enantiomer;Cobimetinib R-enantiomer |
[3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯基][3-羥基-3-[(2R)-2-哌啶基]-1-氮雜環(huán)丁基]甲酮 |
934660-94-3 |
詳細
|
| CNX-500 |
CNX-500 |
1202758-21-1 |
詳細
|
| CMP-Sialic acid sodium salt；CMP-Neu5Ac sodium salt |
CMP-NAN SODIUM SALT |
1007117-62-5 |
詳細
|
| CMLD012612 |
CMLD012612 |
2368900-35-8 |
詳細
|
| CMLD012073 |
CMLD012073 |
2368900-32-5 |
詳細
|
| CP-96486 |
139401-45-9 |
139401-45-9 |
詳細
|
| CP-96021 hydrochloride |
CP-96021 HYDROCHLORIDE |
167011-22-5 |
詳細
|
| CP-547632 hydrochloride |
CP-547632 (hydrochloride) |
252003-71-7 |
詳細
|
| CP-409092 |
194098-25-4 |
194098-25-4 |
詳細
|
| CP-409092 hydrochloride |
CP-409092 HYDROCHLORIDE |
225240-86-8 |
詳細
|
| CP-28888；CP 28888-27 |
N,N-Dihexadecyl-1,3-benzenedi(methanamine) |
69938-75-6 |
詳細
|
| Coumetarol；Ph 137;Dicumoxane |
庫美香豆素 |
4366-18-1 |
詳細
|
| Cot inhibitor-2 |
8-氯-4-[(3-氯-4-氟苯基)氨基]-6-[[[1-(1-乙基-4-哌啶)-1H-1,2,3-三唑-4-基]甲基]氨基]-3-喹啉甲腈 |
915363-56-3 |
詳細
|
| Cot inhibitor-1 |
8-C氯-4-[(3-氯-4-氟苯基)氨基]-6-[[[1-[2-(六氫-1H-氮雜-1-基)乙基]-1H-1,2,3-三唑-4-基]甲基]氨基]-3-喹啉甲腈 |
915365-57-0 |
詳細
|
| CP-809101 hydrochloride |
2-[(3-氯苯基)甲氧基]-6-(1-哌嗪基)吡嗪鹽酸鹽 |
1215721-40-6 |
詳細
|
| Valacyclovir hydrochloride |
鹽酸萬乃洛韋 |
124832-27-5 |
詳細
|
| CP-547632 |
3-[(4-溴-2,6-二氟芐基)氧基]-5-[3-[4-(吡咯烷-1-基)丁基]脲基]異噻唑-4-甲酰胺 |
252003-65-9 |
詳細
|
| CP-060 |
180090-15-7 |
180090-15-7 |
詳細
|
| CPPG；(RS)-CPPG |
CPPG |
183364-82-1 |
詳細
|
| CPPHA |
N-[4-氯-2-[(1,3-二氫-1,3-二氧代-2H-異吲哚-2-基)甲基]苯基]-2-羥基苯甲酰胺 |
693288-97-0 |
詳細
|
| CPFX2090 |
CPFX2090 |
1429439-25-7 |
詳細
|
| CPA inhibitor |
ALPHA-[[羥基(2-苯基乙酰)氨基]甲基]苯丙酸 |
223532-02-3 |
詳細
|
| CPDA |
1415834-63-7 |
1415834-63-7 |
詳細
|
| Repaglinide |
瑞格列奈 |
135062-02-1 |
詳細
|
| CPI-0610 carboxylic acid |
CPI-0610 CARBOXYLIC ACID |
1380089-81-5 |
詳細
|
| CPUY074020 |
CPUY074020 |
902279-44-1 |
詳細
|